Asia-pacific Cellulite Treatment Market Forecast 2023-2032

The Asia-Pacific cellulite treatment market is predicted to grow with a CAGR of 9.78% over the forecasted years of 2023-2032. Key factors, such as the lower cost of treatments and premium healthcare services, the presence of skilled professionals as well as high quality healthcare facilities, and the increasing number of cosmetic procedures, are mainly accredited to the market growth of the region.

MARKET INSIGHTS

The Asia-Pacific cellulite treatment market growth analysis comprises a detailed assessment of China, South Korea, Thailand, Indonesia, Vietnam, Japan, India, Australia & New Zealand, and Rest of Asia-Pacific. As per the World Economic Forum (WEF) data, the number of individuals aged 55 years or above in South Korea increased to 16.7 million in 2020 from 11 million in 2011. Subsequently, the increasing geriatric populace is set to increase the demand for cellulite treatment products, thus leading to market growth.

On the other hand, according to the International Trade Administration (ITA), South Korea is one of the leading beauty markets globally, recognized for its innovation, pleasing packaging, and gentle ingredients. Aligning with this, as per the Korea Customs Service statistics, skincare cosmetics continued to be the greatest import category, equating to 34.17% of total cosmetic imports in the year 2021. Therefore, the rising awareness about cellulite treatment, coupled with the increasing number of aesthetic-conscious individuals in South Korea, is expected to contribute to the overall growth of the cellulite treatment market in the Asia-Pacific during the forecast years.

COMPETITIVE INSIGHTS

Some of the leading companies operating in the market are: Johnson & Johnson, Nubway Co Ltd, AbbVie Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 50826

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. RISING BEAUTY CONSCIOUSNESS
- 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
- 2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
- 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
- 3.1.2. RISING CASES OF OBESITY
- 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
- 3.2.2. SIDE EFFECTS POST-TREATMENT
- 3.2.3. LACK OF AWARENESS

4. KEY ANALYTICS

4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
- 4.7.1. RESEARCH AND DEVELOPMENT
- 4.7.2. PRODUCT DEVELOPMENT
- 4.7.3. MARKETING AND DISTRIBUTION
- 4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
- 4.8.1. COST
- 4.8.2. BRAND REPUTATION
- 4.8.3. USABILITY

5. MARKET BY PROCEDURE

5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL

6. MARKET BY TYPE

6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE

7. MARKET BY END-USER

7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
- 8.1.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
- 8.1.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. CHINA
  - 8.1.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. JAPAN
  - 8.1.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.3. INDIA
  - 8.1.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.4. SOUTH KOREA
  - 8.1.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.5. THAILAND
  - 8.1.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.6. INDONESIA
  - 8.1.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.7. VIETNAM
  - 8.1.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.8. AUSTRALIA & NEW ZEALAND
  - 8.1.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.9. REST OF ASIA-PACIFIC
  - 8.1.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBVIE INC
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. FINANCIAL ANALYSIS
  - 9.2.1.3. PRODUCTS / SERVICES LIST
  - 9.2.1.4. STRENGTHS & CHALLENGES
- 9.2.2. ALMA LASERS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCTS / SERVICES LIST
- 9.2.3. BAUSCH HEALTH COMPANIES INC.
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. FINANCIAL ANALYSIS
  - 9.2.3.3. PRODUCTS / SERVICES LIST
  - 9.2.3.4. STRENGTHS & CHALLENGES
- 9.2.4. CANDELA CORPORATION
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCTS / SERVICES LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CUTERA INC
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. FINANCIAL ANALYSIS
  - 9.2.5.3. PRODUCTS / SERVICES LIST
  - 9.2.5.4. STRENGTHS & CHALLENGES
- 9.2.6. CYNOSURE LLC
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCTS / SERVICES LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. ENDO INTERNATIONAL PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. FINANCIAL ANALYSIS
  - 9.2.7.3. PRODUCTS / SERVICES LIST
  - 9.2.7.4. STRENGTHS & CHALLENGES
- 9.2.8. GALDERMA SA
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCTS / SERVICES LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. INCELER MEDIKAL CO LTD
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCTS / SERVICES LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. JOHNSON & JOHNSON
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. FINANCIAL ANALYSIS
  - 9.2.10.3. PRODUCTS / SERVICES LIST
  - 9.2.10.4. STRENGTHS & CHALLENGES
- 9.2.11. MERZ PHARMA GMBH & CO KGAA
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCTS / SERVICES LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. NUBWAY CO LTD
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCTS / SERVICES LIST
- 9.2.13. SIENTRA INC
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. FINANCIAL ANALYSIS
  - 9.2.13.3. PRODUCTS / SERVICES LIST
  - 9.2.13.4. STRENGTHS & CHALLENGES
- 9.2.14. SINCLAIR PHARMA
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCTS / SERVICES LIST
- 9.2.15. ZIMMER MEDIZINSYSTEME
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCTS / SERVICES LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

Product Code: 50826

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CELLULITE TREATMENT
TABLE 2: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: ASIA-PACIFIC CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: CHINA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: JAPAN CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: INDIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: SOUTH KOREA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: THAILAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: INDONESIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: VIETNAM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 29: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 30: ABBVIE INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 31: ABBVIE INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 32: ABBVIE INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 33: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 34: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 35: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 36: CUTERA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)
FIGURE 37: CUTERA INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 38: CUTERA INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 39: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 - 2021 ($ MILLION)
FIGURE 40: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 41: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 42: JOHNSON & JOHNSON COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 43: JOHNSON & JOHNSON COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 44: JOHNSON & JOHNSON COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 45: JOHNSON & JOHNSON COMPANY REVENUE 2017 - 2021 ($ BILLION)
FIGURE 46: SIENTRA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)